4.4 Article

Use of antibiotics in infancy and childhood and risk of recurrent abdominal pain-a Swedish birth cohort study

期刊

NEUROGASTROENTEROLOGY AND MOTILITY
卷 26, 期 6, 页码 841-850

出版社

WILEY
DOI: 10.1111/nmo.12340

关键词

functional abdominal pain; inflammation; irritable bowel syndrome; microbiology

资金

  1. Stockholm County Council
  2. Swedish Research Council
  3. Swedish Research Council Formas
  4. Swedish Heart and Lung Foundation
  5. Swedish Asthma and Allergy Association
  6. Swedish Foundation for Health Care Science and Allergy Research
  7. Karolinska Institutet [20110237]
  8. Foreningen Mjolkdroppen
  9. Kempe Carlgrenska Foundation
  10. Juhlin Foundation
  11. Karolinska Institutet Funds
  12. Stiftelsen Samariten
  13. Mjolkdroppen Foundation
  14. Jane and Dan Olsson Foundation
  15. Majblomman Foundation
  16. Stockholm county
  17. Orebro University Hospital
  18. Swedish Society of Medicine
  19. Swedish Research Council - Medicine [522-2A09-195]
  20. Sven Jerring Foundation
  21. Orebro Society of Medicine
  22. Clas Groschinsky Foundation
  23. Uppsala-Orebro Regional Research Council
  24. Swedish Celiac Society
  25. Swedish Research Council (SIMSAM grant) [80748301]

向作者/读者索取更多资源

Background The etiology of recurrent abdominal pain of functional origin (AP) is largely unknown. Antibiotic treatment influences the intestinal microbiota, and a few studies have indicated an increased risk of AP in adults after antibiotic treatment. Corresponding data in children are lacking. The aim of this study was to explore the association between antibiotic treatment during childhood and AP at 12years. Methods Two thousand seven hundred and thirty-two children from a Swedish, population-based birth cohort. Parents reported antibiotic use for the children between birth and 2years. Antibiotic use between 9 and 12years was collected from the Swedish Prescribed Drug Register. The children answered questionnaires regarding AP at age 12. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for AP at 12years as a function of antibiotic use. Key Results Antibiotic treatment between 9 and 12years was not associated with AP at 12. Children who had received 3 courses, or broad-spectrum antibiotics between 9 and 12years had an increased risk of AP at 12, but these associations failed to reach statistical significance. Antibiotic treatment during both the first and the second year of life increased the risk of AP in girls at 12 (OR 1.65; 95% CI: 1.09-2.49), but not in boys or the whole cohort. Conclusions & Inferences Antibiotic treatment does not seem to be a major risk factor for AP at 12years. However, we cannot exclude that repeated courses, especially to infant girls, or use of broad-spectrum antibiotics between 9 and 12years may be associated with an increased risk of AP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Allergy

Egg and milk exposure during pregnancy and food reactions in grandchildren

Ida Mogensen, Charlotta Flodstrom, Anna Nopp, Erik Melen, Anna Bergstrom, Inger Kull

ALLERGY (2023)

Article Pediatrics

Regional Swedish study found that one in seven coeliac patients experienced loss of follow up during childhood

Maria Ulnes, Henrik Albrektsson, Ketil Stordal, Robert Saalman, Jonas F. Ludvigsson, Karl Marild

Summary: The aim of this study was to examine the clinical follow up of paediatric coeliac disease and the rate of loss of follow up during childhood. The results showed that 14% of the coeliac patients were lost to follow up after an average of 5.3 years since diagnosis. The patients who were lost to follow up were more often boys and had a slightly longer average disease duration.

ACTA PAEDIATRICA (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: type 1 diabetes, microscopic colitis and the need to explore the complex mechanisms of this association-authors' reply

Xiaoying Kang, Shengxin Liu, Jonas F. Ludvigsson

Summary: This article is related to the papers by Kang et al. To access these articles, please visit...

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children

Hannes Hagstroem, Jonas F. F. Ludvigsson

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Type 1 diabetes and microscopic colitis: A nationwide matched case-control study in Sweden

Xiaoying Kang, Shengxin Liu, Bjorn Roelstraete, Hamed Khalili, Jonas F. Ludvigsson

Summary: This study examined the association between type 1 diabetes (T1D) and microscopic colitis (MC). The results showed that the prevalence of T1D was almost 80% higher in MC patients compared to the general population. This association may be related to the consumption of medications associated with MC onset.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

No Increased Risk of Cardiac Birth Defects in Infants of Mothers With Celiac Disease: A Population and Sibling Comparison

Haley M. Zylberberg, Benjamin Lebwohl, Bjorn Roelstraete, Jonas Soederling, Olof Stephansson, Peter H. R. Green, Jonas F. Ludvigsson

Summary: This study aimed to investigate the risk of cardiac birth defects in infants born to mothers with celiac disease (CeD). The results showed no statistically significant association between maternal CeD and the risk of any or cardiac birth defects in the offspring, compared to the general population and non-affected siblings.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study

Fahim Ebrahimi, Tracey G. Simon, Hannes Hagstrom, Jonas Soderling, Axel Wester, Bjorn Roelstraete, Jonas F. Ludvigsson

Summary: Patients with biopsy-proven NAFLD have a significantly higher risk of developing severe infections requiring hospitalization compared to the general population and their siblings. The risk of infection increases with the severity of NAFLD.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Antibiotic use and inflammatory bowel disease: number needed to harm?

Jonas F. Ludvigsson

Article Surgery

Outcomes of bariatric surgery for patients with prevalent inflammatory bowel disease: A nationwide registry-based cohort study

Andreas Wallhuss, Johan Ottosson, Yang Cao, Ellen Andersson, Daniel Bergemalm, Carl Eriksson, Ola Olen, Eva Szabo, Erik Stenberg

Summary: This study aimed to evaluate the safety and effectiveness of bariatric surgery in obese patients with inflammatory bowel disease. The results showed that sleeve gastrectomy was a safe and effective option for weight loss in patients with both Crohn's disease and ulcerative colitis, while Roux-en-Y gastric bypass was associated with a higher risk of postoperative complications in patients with ulcerative colitis.

SURGERY (2023)

Review Behavioral Sciences

Psychological treatments for irritable bowel syndrome: a comprehensive systematic review and meta-analysis

Erland Axelsson, Dorian Kern, Erik Hedman-Lagerlof, Perjohan Lindfors, Josefin Palmgren, Hugo Hesser, Erik Andersson, Robert Johansson, Ola Olen, Marianne Bonnert, Maria Lalouni, Brjann Ljotsson

Summary: This systematic review and meta-analysis examined the effects of various psychological treatments on irritable bowel syndrome (IBS). The results showed that exposure therapy and hypnotherapy had significant additional effects compared to attention controls. Exposure therapy was found to be a particularly promising treatment for IBS.

COGNITIVE BEHAVIOUR THERAPY (2023)

Article Public, Environmental & Occupational Health

Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019

Patrik Nasr, Erik von Seth, Raphaela Mayerhofer, Nelson Ndegwa, Jonas F. F. Ludvigsson, Hannes Hagstrom

Summary: The incidence rates of non-alcoholic fatty liver disease, alcohol-related cirrhosis, unspecified liver cirrhosis, and liver malignancies have increased in Sweden over the last 15 years. There has also been an increase in mortality rates for several liver diseases. Significant disparities across sex and geographical regions need to be considered when allocating healthcare resources.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Gastroenterology & Hepatology

Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study

Fahim Ebrahimi, Tracey G. Simon, Hannes Hagstrom, Jiangwei Sun, David Bergman, Anders Forss, Bjorn Roelstraete, Lars Engstrand, Jonas F. Ludvigsson

Summary: Antibiotic use may increase the risk of developing nonalcoholic fatty liver disease (NAFLD), especially in individuals without metabolic syndrome. Fluoroquinolones were found to have the highest risk, and the associations remained robust in sibling comparisons.

LIVER INTERNATIONAL (2023)

Article Medicine, General & Internal

Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study

Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundstrom, Anders Forss, Ola Olen, Jonas F. Ludvigsson

Summary: This study found that patients with inflammatory bowel disease (IBD) have an increased risk of developing arrhythmias. This increased risk persists even 25 years after the diagnosis of IBD.

PLOS MEDICINE (2023)

Article Allergy

A molecular sensitization map of European children reveals exposome- and climate-dependent sensitization profiles

M. B. Gea Kiewiet, Christian Lupinek, Susanne Vrtala, Sandra Wieser, Alexandra Baar, Renata Kiss, Inger Kull, Erik Melen, Magnus Wickman, Daniela Porta, Davide Gori, Ulrike Gehring, Rob Aalberse, Jordi Sunyer, Marie Standl, Joachim Heinrich, Dagmar Waiblinger, John Wright, Josep M. Anto, Jean Bousquet, Marianne van Hage, Rudolf Valenta

Summary: The study analyzed the IgE sensitization profiles in more than 2800 children from different regions of Europe and found regional, exposome- and climate-dependent differences in molecular IgE-reactivity profiles. These findings provide the basis for precision medicine-based approaches for allergy treatment and prevention.

ALLERGY (2023)

Letter Gastroenterology & Hepatology

Letter: Antibiotics prescription and new-onset irritable bowel syndrome-Authors' reply

Kyle Staller, Jonas F. Ludvigsson

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

暂无数据